Exam 2: NSG555/ NSG 555 (Latest 2023/ 2024 Update) Nurse Practitioners in Primary Care II Exam| Questions and Verified Answers| 100% Correct| Grade A

Exam 2: NSG555/ NSG 555 (Latest 2023/ 2024 Update) Nurse Practitioners in Primary Care II Exam| Questions and Verified Answers| 100% Correct| Grade A Q: Diff between acyclovir and HIV drugs Answer: acyclovir competes for Viral DNA nor RT. Q: Acyclovir unique site Answer: a VIRAL (not human) Q: ValGANcyclovir toxicity reason Answer: has more affinity for human DNA polymerase Q: Why won't ioxuridine and trifluridine work in RNA viruses? Answer: RNA does NOT use Thymidine, but Uracil Q: INFECTIUOS HEP Answer: Hep A or other infections (acute). B and C are CHRONIC) Q: which hep viris is DNA based Answer: Hep B (Hep C is RNA based) Q: INFalpha and INF gamma role in HCV initial infecition Answer: inhibit viral replication. Released by hepatocyte in response to infection. -→ ISG transcription and translation Q: IFN effects 5 points -→ ISG effects Answer: inhibit transcription, translation, post-transitional processing, virus maturation, virus release Q: How many infected with HCV progress to chronic? Answer: 70% (30% is cleared naturally) Q: Predictors of positive response Hep C 1. HCV-1 genetoype (1/2 infected IFN remain permanently active, will clear the). IFNL3 strong ISG response. Males, AA, older age - more ISG response